Start Of Grant Term:
November 1, 2026
Precious Jules Childhood Cancer Foundation, a non-profit organization dedicated to the elimination of childhood cancer through innovative research in pediatric oncology, invites letters of intent for funding of projects in the following areas:
Basic, Translational, Clinical, and Applied Research Projects and Fellowship
Letter of Intent (LOI)
Open April 30th, 2026, through May 31st, 2026, at 5 p.m. ET (2 p.m. PT)
PJCCF Review of LOIs: May 31st, 2026, through June 15th, 2026
Notification for Full Application: June 16th, 2026
Full Application
(For those invited to apply based on the Letter of Intent)
Open June 16th, 2026, through July 30th, 2026
Final Application Due: July 30th, 2026, at 5:00 p.m. ET (2:00 p.m. PT)
PJCCF Review of Applications: July 31st, 2026, through August 31st, 2026
Selection of Recipient and Notification after September 3rd, 2026
Presentation of Award at Precious Jules Childhood Cancer Foundation Banquet Dinner:
October 24, 2026, at The Westwood, in Garwood, NJ
(attendance by award winner requested – see page 8)
Dr. Julia Warren | 2024 PJCCF GRANT RECIPIENT
Pediatric Oncologist at Children’s Hospital of Philadelphia (Philadelphia, PA)
Pediatric Oncologist at Children’s Hospital of Philadelphia (Philadelphia, PA) awarded the Precious Jules Childhood Cancer Foundation Pediatric Oncology Grant in amount of $50,000 “Targeting Mitochondrial Proteostasis for Myeloid Leukemia Therapeutics”
ADAM KEBEDE, MD | 2023 PJCCF GRANT RECIPIENT
POSTDOCTORAL RESEARCH FELLOW, DEPARTMENT OF PEDIATRIC ONCOLOGY
DANA FARBER CANCER INSTITUTE, BOSTON
GRANT PERIOD: 11/01/2023-10/31/2024
GRANT AMOUNT RECEIVED: $50,000
“THE ROLE OF PPM1D TRUNCATING MUTATIONS IN DRIVING THE DEVELOPMENT OF PEDIATRIC DIFFUSE MIDLINE GLIOMAS”
LISA NISWANDER, MD | 2022 PJCCF GRANT RECIPIENT
FELLOW PHYSICIAN, PEDIATRIC HEMATOLOGY/ONCOLOGY
CHILDREN’S HOSPITAL OF PHILADELPHIA
GRANT PERIOD: 04/22/2022-04/21/2023
GRANT AMOUNT RECEIVED: $50,000
“MEK INHIBITION TO IMPROVE CAR T CELL IMMUNOTHERAPY FOR HIGH-RISK PEDIATRIC LEUKEMIA”
JULIE GUEST, MD | 2019 PJCCF GRANT RECIPIENT
FELLOW PHYSICIAN, PEDIATRIC HEMATOLOGY/ONCOLOGY
JOHN HOPKIN’S UNIVERSITY MEDICAL CENTER/NATIONAL INSTITUTE OF HEALTH
GRANT PERIOD: 11/1/2019-10/31/2020
GRANT AMOUNT RECEIVED: $35,000
“THE IMMUNOBIOLOGY OF BLINATUMOMAB RESPONSE AND RESISTANCE IN HIGH-RISK RELAPSEDPEDIATRIC B-ACUTE LYMPHOBLASTIC LEUKEMIA”
CAITLIN ELGARTEN, MD | 2018 PJCCF GRANT RECIPIENT
FELLOW PHYSICIAN, PEDIATRIC HEMATOLOGY/ONCOLOGY
CHILDREN’S HOSPITAL OF PHILADELPHIA
GRANT PERIOD: 11/1/2018-10/31/2019
GRANT AMOUNT RECEIVED: $30,000
“INVESTIGATING THE GUT MICROBIOME PRIOR TO HEMATOPOIETIC CELL TRANSPLANT AS A POTENTIAL TARGET TO MITIGATE GRAFT-VERSUS-HOST DISEASE”
RYAN SUMMERS, MD, FAAP | 2017 PJCCF GRANT RECIPIENT
CHIEF FELLOW, PEDIATRIC HEMATOLOGY/ONCOLOGY
AFLAC CANCER AND BLOOD DISORDERS CENTER. CHILDREN’S HEALTHCARE OF ATLANTA- EMORY UNIVERSITY SCHOOL OF MEDICINE
GRANT PERIOD: 11/01/2017 -10/31/2018
GRANT AMOUNT RECEIVED: $25,000
“THERAPEUTIC TARGETING OF MERKT AND BCL-2 IN EARLY PRECURSOR ALL.”
SUZANNE MACFARLAND, MD | 2016 PJCCF GRANT RECIPIENT
ATTENDING PHYSICIAN, PEDIATRIC HEMATOLOGY/ONCOLOGY
CHILDREN’S HOSPITAL OF PHILADELPHIA
GRANT PERIOD: 11/01/2016—10/31/2017
GRANT AMOUNT RECEIVED: $20,000
“IDENTIFICATION OF UNDERLYING GENETIC ABERRATIONS IN JUVENILE POLYPOSIS SYNDROME (JPS) AND MALIGNANCY IN GENOTYPE/PHENOTYPING”